Eris Lifesciences informs about disclosure

24 Sep 2022 Evaluate
Eris Lifesciences has informed that the Company has received today the attached request letter dated 19th September, 2022, from Shah & Co., constituent of Promoter Group of Kaushal Shah, Promoter of the Company, seeking a reclassification from 'Promoter Group' to 'Pubic' category, for the reasons appearing therein. The request will be considered by the Board of Directors of the Company and all appropriate approvals will be sought by the Company as set out in Regulation 31A of Listing Regulations.

The above information is a part of company’s filings submitted to BSE.

Eris Lifesciences Share Price

907.10 9.95 (1.11%)
21-May-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1532.00
Dr. Reddys Lab 5780.70
Cipla 1442.00
Zydus Lifesciences 1088.45
Lupin 1683.50
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.